November 12, 2012 Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer

[at noodls] – November 12, 2012 Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer Québec City, Canada, November 12, 2012 – Aeterna Zentaris Inc. (NASDAQ: AEZS) … more

View todays social media effects on AEZS

View the latest stocks trending across Twitter. Click to view dashboard